Fees in Respect of Drugs and Medical Devices Order
Marginal note:Remission — performance standard
6 (1) If the Minister determines that the performance standard has not been met in relation to a fee that is payable under this Order, remission is granted to the person that must pay the fee
(a) of an amount equal to 25% of the fee; or
(b) of an amount equal to 25% of the amount that is payable, in the case where remission is granted of part of the fee under any other provision of this Order.
(2) Subsection (1) does not apply to a fee for the examination of
(a) an application or submission referred to in this Order in respect of which a joint or parallel review is conducted by the Minister and a foreign regulatory authority;
(b) an application for a licence that is filed under section 32 of the Medical Devices Regulations if
(i) the medical device to which the application relates includes a component that is a drug, and
(ii) the Minister has made a decision in respect of the application to issue or amend a medical device licence under section 36 of those Regulations, or to refuse to issue or amend such a licence under section 38 of those Regulations; or
(c) a new drug submission for a designated COVID-19 drug if subsection C.08.002(2.3) of the Food and Drug Regulations applies to that submission.
- SOR/2021-47, s. 1
- Date modified: